DELANEY HARTMAN: Open Payments
NPI 1255093514 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 58 payments from 25 companies in 2025. Trend: 2023 $697 · 2024 $1,144 · 2025 $1,449
Food & beverage: $1,329Education: $120
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $176 |
| UROGEN PHARMA, INC. | 7 | $175 |
| PFIZER INC. | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| ACCORD HEALTHCARE, INC. | 4 | $104 |
| Boston Scientific Corporation | 2 | $95 |
| SEAGEN INC. | 1 | $85 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
Products named: XTANDI, JELMYTO, PLUVICTO, Camcevi, ORGOVYX, GEMTESA, AMS 700, PYLARIFY.
Industry payments across IN — which companies pay providers there.
